Symtomax
PrivateCompany Overview
Symtomax operates in Healthcare & Life Sciences and is based in Beja. It was founded in 2017.
Symtomax is a pharmaceutical and agricultural company that specializes in the cultivation, production, and distribution of medical-grade cannabis oil and cannabinoid-based products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symtomax Comparables
Compare Symtomax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AceCann | 90% | |
| GreenBE Pharma | 89% | |
| Linneo Health | 87% |
For institutional investors. Book with your work email.
Symtomax Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2026
Monthly visitors increased 57% MoM.
For institutional investors. Book with your work email.
Symtomax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Symtomax's valuation, stock price, and market status.
Is Symtomax a public or private company?
Symtomax is a private company.
What is the current stock price of Symtomax?
Symtomax is a private company, so its shares have no public market price. Caplight tracks Symtomax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Symtomax worth (valuation)?
Valuation information for Symtomax is not publicly available.
Can I buy Symtomax stock?
Symtomax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Symtomax's last funding round?
Funding round information for Symtomax is not publicly available.
Who are the main investors in Symtomax?
Investor information for Symtomax is not publicly disclosed.
Will Symtomax IPO soon?
No public IPO plans have been announced for Symtomax.
How can I track Symtomax secondary market activity?
Caplight tracks bids, offers, and trades in Symtomax's shares on secondary markets.